Somatic mRNA Turnover Mutants Implicate Tristetraprolin in the Interleukin-3 mRNA Degradation Pathway

ABSTRACT Control of mRNA stability is critical for expression of short-lived transcripts from cytokines and proto-oncogenes. Regulation involves an AU-rich element (ARE) in the 3′ untranslated region (3′UTR) and cognatetrans-acting factors thought to promote either degradation or stabilization of the mRNA. In this study we present a novel approach using somatic cell genetics designed to identify regulators of interleukin-3 (IL-3) mRNA turnover. Mutant cell lines were generated from diploid HT1080 cells transfected with a reporter construct containing green fluorescent protein (GFP) linked to the IL-3 3′UTR. GFP was expressed at low levels due to rapid decay of the mRNA. Following chemical mutagenesis and selection of GFP-overexpressing cells, we could isolate three mutant clones (slowA, slowB, and slowC) with a specific, trans-acting defect in IL-3 mRNA degradation, while the stability of IL-2 and tumor necrosis factor alpha reporter transcripts was not affected. Somatic cell fusion experiments revealed that the mutants are genetically recessive and form two complementation groups. Expression of the tristetraprolin gene in both groups led to reversion of the mutant phenotype, thereby linking this gene to the IL-3 mRNA degradation pathway. The genetic approach described here should allow identification of the defective functions by gene transfer and is also applicable to the study of other mRNA turnover pathways.

[1]  H. Diggelmann,et al.  Hygromycin B phosphotransferase as a selectable marker for DNA transfer experiments with higher eucaryotic cells , 1984, Molecular and cellular biology.

[2]  G. Shaw,et al.  A conserved AU sequence from the 3′ untranslated region of GM-CSF mRNA mediates selective mRNA degradation , 1986, Cell.

[3]  B. Beutler,et al.  Identification of a common nucleotide sequence in the 3'-untranslated region of mRNA molecules specifying inflammatory mediators. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[4]  M. Cole,et al.  Rapid cytoplasmic turnover of c-myc mRNA: requirement of the 3' untranslated sequences , 1987, Molecular and cellular biology.

[5]  G. Schuler,et al.  GM-CSF and oncogene mRNA stabilities are independently regulated in trans in a mouse monocytic tumor , 1988, Cell.

[6]  N. Gough.  Rapid and quantitative preparation of cytoplasmic RNA from small numbers of cells. , 1988, Analytical biochemistry.

[7]  V. Sukhatme,et al.  Nucleotide sequence of a cDNA encoding TIS11, a message induced in Swiss 3T3 cells by the tumor promoter tetradecanoyl phorbol acetate. , 1989, Oncogene.

[8]  G. Stark,et al.  Use of a selectable marker regulated by alpha interferon to obtain mutations in the signaling pathway , 1989, Molecular and cellular biology.

[9]  M. Greenberg,et al.  The c-fos transcript is targeted for rapid decay by two distinct mRNA degradation pathways. , 1989, Genes & development.

[10]  H. Hirsch,et al.  Tumor suppression involves down-regulation of interleukin 3 expression in hybrids between autocrine mastocytoma and interleukin 3-dependent parental mast cells. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[11]  J. Ross,et al.  Regulation of c-myc mRNA stability in vitro by a labile destabilizer with an essential nucleic acid component , 1989, Molecular and cellular biology.

[12]  V. Kindler,et al.  A v-H-ras-dependent hemopoietic tumor model involving progression from a clonal stage of transformation competence to autocrine interleukin 3 production , 1989, Molecular and cellular biology.

[13]  H. Land,et al.  Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. , 1990, Nucleic acids research.

[14]  N. Andrews,et al.  Positive and negative elements regulate human interleukin 3 expression. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[15]  G. Brewer,et al.  An A + U-rich element RNA-binding factor regulates c-myc mRNA stability in vitro , 1991, Molecular and cellular biology.

[16]  G. Stark,et al.  Isolation and characterization of a new mutant human cell line unresponsive to alpha and beta interferons , 1991, Molecular and cellular biology.

[17]  R. Wisdom,et al.  The protein-coding region of c-myc mRNA contains a sequence that specifies rapid mRNA turnover and induction by protein synthesis inhibitors. , 1991, Genes & development.

[18]  H. Herschman,et al.  A corrected sequence for the predicted protein from the mitogen-inducible TIS11 primary response gene. , 1991, Oncogene.

[19]  P. Erb,et al.  Functional heterogeneity of CD4-positive T-cell subsets: the correlation between effector functions and lymphokine secretion is limited. , 1991, Cellular immunology.

[20]  G. Stark,et al.  High-frequency mutagenesis of human cells and characterization of a mutant unresponsive to both alpha and gamma interferons. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[21]  H. Hirsch,et al.  Mast cells sensitive to v-H-ras transformation are hyperinducible for interleukin 3 expression and have lost tumor-suppressor activity. , 1992, Oncogene.

[22]  J. Gnarra,et al.  Identification of the von Hippel-Lindau disease tumor suppressor gene. , 1993, Science.

[23]  W Zhang,et al.  Purification, characterization, and cDNA cloning of an AU-rich element RNA-binding protein, AUF1 , 1993, Molecular and cellular biology.

[24]  M. Greenberg,et al.  The destabilizing elements in the coding region of c-fos mRNA are recognized as RNA , 1993, Molecular and cellular biology.

[25]  H. Hirsch,et al.  Suppressible and nonsuppressible autocrine mast cell tumors are distinguished by insertion of an endogenous retroviral element (IAP) into the interleukin 3 gene , 1993, The Journal of experimental medicine.

[26]  H. Hirsch,et al.  Cyclosporin A inhibits growth of autocrine tumour cell lines by destabilizing interleukin-3 mRNA , 1994, Nature.

[27]  G. Stoecklin,et al.  Functional hierarchy of AUUUA motifs in mediating rapid interleukin-3 mRNA decay. , 1994, The Journal of biological chemistry.

[28]  J. Ross,et al.  mRNA stability in mammalian cells. , 1995, Microbiological reviews.

[29]  C. Y. Chen,et al.  AU-rich elements: characterization and importance in mRNA degradation. , 1995, Trends in biochemical sciences.

[30]  N. Andrews,et al.  Multiple Proteins Interact with the Nuclear Inhibitory Protein Repressor Element in the Human Interleukin-3 Promoter (*) , 1995, The Journal of Biological Chemistry.

[31]  H. Hirsch,et al.  Interleukin-3 mRNA Stabilization by a trans-Acting Mechanism in Autocrine Tumors Lacking Interleukin-3 Gene Rearrangements (*) , 1995, The Journal of Biological Chemistry.

[32]  Roy Parker,et al.  Degradation of mRNA in eukaryotes , 1995, Cell.

[33]  M J Thompson,et al.  Phosphorylation of Tristetraprolin, a Potential Zinc Finger Transcription Factor, by Mitogen Stimulation in Intact Cells and by Mitogen-activated Protein Kinase in Vitro(*) , 1995, The Journal of Biological Chemistry.

[34]  B. Haynes,et al.  A pathogenetic role for TNF alpha in the syndrome of cachexia, arthritis, and autoimmunity resulting from tristetraprolin (TTP) deficiency. , 1996, Immunity.

[35]  S. Peltz,et al.  Interrelationships of the pathways of mRNA decay and translation in eukaryotic cells. , 1996, Annual review of biochemistry.

[36]  W. Kaelin,et al.  Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[37]  R. Klausner,et al.  Post-transcriptional regulation of vascular endothelial growth factor mRNA by the product of the VHL tumor suppressor gene. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[38]  Anne Wright,et al.  Cloning and Characterization of HuR, a Ubiquitously Expressed Elav-like Protein (*) , 1996, The Journal of Biological Chemistry.

[39]  J. Laubach,et al.  Cooperation between Core Binding Factor and Adjacent Promoter Elements Contributes to the Tissue-specific Expression of Interleukin-3* , 1996, The Journal of Biological Chemistry.

[40]  J. Steitz,et al.  Identification of HuR as a protein implicated in AUUUA‐mediated mRNA decay , 1997, The EMBO journal.

[41]  A. Levy,et al.  Hypoxic Stabilization of Vascular Endothelial Growth Factor mRNA by the RNA-binding Protein HuR* , 1998, The Journal of Biological Chemistry.

[42]  P. Blackshear,et al.  Feedback inhibition of macrophage tumor necrosis factor-alpha production by tristetraprolin. , 1998, Science.

[43]  P. Blackshear,et al.  Feedback Inhibition of Macrophage Tumor Necrosis Factor-α Production by Tristetraprolin , 1998 .

[44]  A. Shyu,et al.  RNA stabilization by the AU‐rich element binding protein, HuR, an ELAV protein , 1998, The EMBO journal.

[45]  C. Moroni,et al.  c‐jun N‐terminal kinase is involved in AUUUA‐mediated interleukin‐3 mRNA turnover in mast cells , 1998, The EMBO journal.

[46]  J. Steitz,et al.  Overexpression of HuR, a nuclear–cytoplasmic shuttling protein, increases the in vivo stability of ARE‐containing mRNAs , 1998, The EMBO journal.

[47]  C. Y. Chen,et al.  Unraveling a cytoplasmic role for hnRNP D in the in vivo mRNA destabilization directed by the AU-rich element. , 1999, Genes & development.

[48]  P. Blackshear,et al.  Evidence that Tristetraprolin Binds to AU-Rich Elements and Promotes the Deadenylation and Destabilization of Tumor Necrosis Factor Alpha mRNA , 1999, Molecular and Cellular Biology.

[49]  M. Gstaiger,et al.  The von Hippel-Lindau tumor suppressor protein is a component of an E3 ubiquitin-protein ligase activity. , 1999, Genes & development.

[50]  C. Moroni,et al.  Calcium-Dependent and Oncogenic IL-3 mRNA Stabilization can be Distinguished Pharmacologically and by Sequence Requirements in the 3′UTR , 2000, Growth factors.